RTTNews | Nov 5, 2021 10:23AM EDT

10:23 Friday, November 5, 2021 (RTTNews.com) - Maryland-based healthcare company, Emergent BioSolutions Inc. (EBS), is trading 32% lower in the Friday market on news of termination of a government deal.

The company's facility in Baltimore was allegedly involved in contamination of Johnson and Johnson's Covid-19 vaccine back in March. The event delayed the process of vaccine production curing a critical time. This has led to the government cancelling the contract with the company worth $180 million. The event was filed by the company in a filing with the SEC.

The stock is currently trading at $35.60, down $17.01 or 32.32% since the previous close at $52.61. The shares opened at $40.11 in the morning. In the 52-week period, the shares have ranged between $35.21 and $127.20

Read the original article on RTTNews ( https://www.rttnews.com/3240104/emergent-biosolutions-drops-32-on-government-contract-termination.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved